Search PDMR transactions

Notifier
Name
Anna Frostegård
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Anna Frostegård
Position
Chief Scientific and Medical Officer
Initial notification
Yes
Amendment
No
Details of amendment
Issuer
Name of issuer
Annexin Pharmaceuticals via Annexin Incentive
LEI code
5493000JP703HGPJEX27
Details of transaction
Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Trading venue
teckningsoption Subscription 309,464 Quantity 0.48 SEK 30/04/2018 FIRST NORTH SWEDEN
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Trading venue Volume Weighted average price
teckningsoption Subscription 30/04/2018 FIRST NORTH SWEDEN 309,464 (Quantity) 0.48 SEK
Total: 309,464
<< Back